Genie Energy Ltd. (0IUS)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 16.74 |
|---|---|
| 52-week range | 12.87 – 27.54 |
| Return, 1 month / 3 months | +2.4% / +16.7% |
| Return, 1 year / 3 years | +6.9% / – |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 36.7% |
| Worst drawdown (1 year) | -18.6% |
| Average daily value traded | 0.00M USD |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Genie Energy Ltd. is a retail energy provider that supplies electricity and natural gas to homes and small businesses, mainly in the United States. Through its retail subsidiaries, the company buys power and gas on wholesale markets and resells it to customers under its own supply arrangements. It also holds oil shale exploration interests in Israel. Genie Energy is based in the United States and serves residential and commercial energy users.
Genie Energy Ltd. trades under the code 0IUS on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Genie Energy Ltd. (0IUS) trades on the London Exchange in UK. It last closed at USD 16.74 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 876 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.9% and over the last three months it rose 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | – | ||
| From 52-week high | -1.4% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 16.7% | ||
| 6-month return | 23.7% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.6% | ||
| Liquidity | 9 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M USD | ||
| Zero-volume days | 3.3% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +2.4% |
| 3 months | +16.7% |
| 6 months | +23.7% |
| 1 year | +6.9% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 15.77 / 14.65 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.0750 |
| 22 May 2026 | USD 0.0750 |
| 18 Feb 2026 | USD 0.0750 |
| 10 Nov 2025 | USD 0.0750 |
| 11 Aug 2025 | USD 0.0750 |
| 19 May 2025 | USD 0.0750 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.